- Home
- ANNX vs FET Comparison
ANNX vs FET Comparison
Compare ANNX & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- FET
- Stock Information
- Founded
- ANNX 2011
- FET 2005
- Country
- ANNX United States
- FET United States
- Employees
- ANNX N/A
- FET N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- FET Metal Fabrications
- Sector
- ANNX Health Care
- FET Industrials
- Exchange
- ANNX Nasdaq
- FET Nasdaq
- Market Cap
- ANNX 263.3M
- FET 240.1M
- IPO Year
- ANNX 2020
- FET 2012
- Fundamental
- Price
- ANNX $2.42
- FET $18.93
- Analyst Decision
- ANNX Strong Buy
- FET
- Analyst Count
- ANNX 4
- FET 0
- Target Price
- ANNX $12.50
- FET N/A
- AVG Volume (30 Days)
- ANNX 1.7M
- FET 82.6K
- Earning Date
- ANNX 08-11-2025
- FET 08-07-2025
- Dividend Yield
- ANNX N/A
- FET N/A
- EPS Growth
- ANNX N/A
- FET N/A
- EPS
- ANNX N/A
- FET N/A
- Revenue
- ANNX N/A
- FET $807,312,000.00
- Revenue This Year
- ANNX N/A
- FET N/A
- Revenue Next Year
- ANNX N/A
- FET $1.56
- P/E Ratio
- ANNX N/A
- FET N/A
- Revenue Growth
- ANNX N/A
- FET 7.31
- 52 Week Low
- ANNX $1.29
- FET $12.78
- 52 Week High
- ANNX $7.85
- FET $21.57
- Technical
- Relative Strength Index (RSI)
- ANNX 47.32
- FET 45.96
- Support Level
- ANNX $2.29
- FET $19.12
- Resistance Level
- ANNX $2.62
- FET $19.19
- Average True Range (ATR)
- ANNX 0.17
- FET 0.72
- MACD
- ANNX -0.01
- FET -0.21
- Stochastic Oscillator
- ANNX 37.74
- FET 28.08
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.